Potential Drugs and Chemotherapeutants for Marine Shrimp Production: Selection, Evaluation, and Approval Processes, Year 02
July 1, 1988
|Hawaii||$165,704||University of Arizona, University of Hawaii at Manoa, and Hawaii Aquaculture Development Program||D.V. Lightner, T.A. Bell, R. Fujioka, J.A. Brock, and J. Controulis|
- Define significant disease problems of penaeid shrimp rearing facilities, and in particular those disease that appear to be potentially treatable.
- Identify and test likely drugs and/or chemotherapeutants for the treatment of disorders or syndromes, previously defined (in #1 above) as potentially treatable. Additional criteria for the selection of candidate compounds will be: reported efficacy and potential for government approval under current Federal regulations.
- In cooperation with an industry sponsor(s), obtain approval for the selected compound(s) form the appropriate Federal government agency.
- Perform studies that will identify and lead to the approval of one of more orally administered (via prepared feeds) antibacterial therapeutants.